Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janelle M Hoskins

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Pharmacogenomics|July 7, 2010
Irinotecan pharmacogenomicsSharon Marsh, Janelle M Hoskins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
UGT1A and irinotecan toxicity: keeping it in the familyJanelle M Hoskins, Howard L McLeod
Trends in Molecular Medicine|March 11, 2011
Copy number variants in pharmacogenetic genesYijing He, Janelle M Hoskins, Howard L McLeod
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 17, 2005
Comment on "A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502d7 that demethylates codeine to morphine", J Biol Chem 279: 27383-27389Janelle M Hoskins, Sharon Marsh, Howard L McLeod
Current Opinion in Molecular Therapeutics|May 30, 2009
Nevirapine hypersensitivity reaction: will the real HLA please stand up?Janelle M Hoskins, Mary W Roederer, Howard L McLeod
European Journal of Clinical Pharmacology|September 19, 2003
Concordance between proguanil phenotype and CYP2C19 genotype in ChineseJanelle M Hoskins, Gillian M Shenfield, Annette S Gross
Nature Reviews. Cancer|July 25, 2009
CYP2D6 and tamoxifen: DNA matters in breast cancerJanelle M Hoskins, Lisa A Carey, Howard L McLeod
Breast (Edinburgh, Scotland)|November 17, 2009
Pharmacogenetics of breast cancer therapiesDaniel L Hertz, Howard L McLeod, Janelle M Hoskins
Molecules (Basel, Switzerland)|January 19, 2017
Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLDYing Xie, Sonia R Miranda, Janelle M Hoskins, et al.
Pharmacogenomics|December 15, 2010
Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresisFabienne Thomas, Janelle M Hoskins, Anne Dvorak, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Pharmacogenomics|July 7, 2010
Irinotecan pharmacogenomicsSharon Marsh, Janelle M Hoskins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
UGT1A and irinotecan toxicity: keeping it in the familyJanelle M Hoskins, Howard L McLeod
Trends in Molecular Medicine|March 11, 2011
Copy number variants in pharmacogenetic genesYijing He, Janelle M Hoskins, Howard L McLeod
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 17, 2005
Comment on "A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502d7 that demethylates codeine to morphine", J Biol Chem 279: 27383-27389Janelle M Hoskins, Sharon Marsh, Howard L McLeod
Current Opinion in Molecular Therapeutics|May 30, 2009
Nevirapine hypersensitivity reaction: will the real HLA please stand up?Janelle M Hoskins, Mary W Roederer, Howard L McLeod
European Journal of Clinical Pharmacology|September 19, 2003
Concordance between proguanil phenotype and CYP2C19 genotype in ChineseJanelle M Hoskins, Gillian M Shenfield, Annette S Gross
Nature Reviews. Cancer|July 25, 2009
CYP2D6 and tamoxifen: DNA matters in breast cancerJanelle M Hoskins, Lisa A Carey, Howard L McLeod
Breast (Edinburgh, Scotland)|November 17, 2009
Pharmacogenetics of breast cancer therapiesDaniel L Hertz, Howard L McLeod, Janelle M Hoskins
Molecules (Basel, Switzerland)|January 19, 2017
Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLDYing Xie, Sonia R Miranda, Janelle M Hoskins, et al.
Pharmacogenomics|December 15, 2010
Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresisFabienne Thomas, Janelle M Hoskins, Anne Dvorak, et al.
Pageof 3